Jan 11 (Reuters) - U.S. Food and Drug Administration:
* U.S. FDA SAYS IS REQUIRING SAFETY LABELING CHANGES TO LIMIT USE OF PRESCRIPTION OPIOID COUGH MEDICINES WITH CODEINE/HYDROCODONE IN CHILDREN BELOW 18 YRS
* ‍U.S. FDA SAYS LABELING FOR PRESCRIPTION OPIOID COUGH MEDICINES WITH CODEINE/HYDROCODONE BEING UPDATED FOR ADULT USE, INCLUDING EXPANDED BOXED WARNING‍​​ Source text: ( bit.ly/2Ex6nUe )
Our Standards: The Thomson Reuters Trust Principles.